Mandy Pinheiro, Ph.D.

Development of First-in-Class, Non-Hormonal TDO2 Inhibitors for the Treatment of Uterine Fibroids.

Mandy Pinheiro, PhD, is Co-Founder of Evina Biosciences and an NIH-funded principal investigator focused on advancing new therapeutic strategies for women’s health. As an Entrepreneurial Fellow at the Chicago Biomedical Consortium, she leads drug discovery and translational development efforts to advance uterine fibroid research originating from the laboratory of Serdar Bulun, MD. Dr. Pinheiro received her PhD in Molecular Biology, Cell Biology & Biochemistry from Boston University.